Results 51 to 60 of about 39,155 (203)
Anti-Müllerian hormone: structure, properties and appliance
Anti-Müllerian hormone (AMH) is a glycoprotein produced by the granulosa cells of preantral and small antral follicles. AMH concentrations reflect ovarian physiology with high precision, thus serving as a more sensitive marker of the ovarian reserve than
Leszcz, Agnieszka +6 more
core +1 more source
Anti-Mullerian Hormone Role in In Vitro Fertilization Outcome
Background and objectives: The in vitro fertilization plays a significant role for human development in last decades. Anti-müllerian hormone level evaluation is indicator of ovarian reserve.
Chiman Khudhur Mawlood
doaj +1 more source
Abstract Intrauterine insemination (IUI) is a widely used first‐line fertility treatment, yet its success rates vary considerably. This review synthesizes evidence from peer‐reviewed studies published between 2000 and 2024, including randomized controlled trials, cohort and case–control studies, as well as systematic and narrative reviews identified ...
Kasuni Akalanka
wiley +1 more source
Background: This study aims to evaluate the correlation between anti-Müllerian hormone, luteinizing hormone, follicle-stimulating hormone, thyroid-stimulating hormone, Estradiol, and vitamin D in women experiencing secondary infertility.
Zahra Moradi Ghadi +7 more
doaj +1 more source
Abstract Objectives Spontaneous premature ovarian insufficiency (POI) is a condition characterized by the cessation of ovarian function before age 40, unrelated to medical interventions. It affects approximately 3.5% of women worldwide and can result in significant emotional, physical, and social consequences.
Maria Patricia Roman +2 more
wiley +1 more source
Severe surgically confirmed endometriosis was associated with a lower prevalence of steatotic liver disease than non‐severe disease. Higher estradiol levels may partly explain this inverse hepatic–reproductive association, supporting integrated gynecologic and hepatologic risk assessment.
Jung Hyun Park +5 more
wiley +1 more source
Anti-Müllerian hormone in premenopausal women following treatment of uterine cervical cancer
In this longitudinal study we prospectively enrolled 32 premenopausal women (ages 23-44years) with stage I-III uterine cervical cancer undergoing surgery and/or chemoradiation.
Bergmark, Karin, +4 more
core +1 more source
Abstract Objective To examine the effect of controlled ovarian stimulation (COS) protocol on follicular synchrony in a subsequent in vitro fertilization (IVF) cycle in patients whose previous cycle was canceled due to asynchrony. Methods A single‐center retrospective‐cohort study (January 2018–March 2024), including women undergoing IVF who had: (1) a ...
Alyssa Hochberg +5 more
wiley +1 more source
Serum anti-Müllerian hormone concentrations vary significantly over time and this should be taken into account when tailoring treatment protocols for patients undergoing controlled ovarian hyperstimulation (COH).
Pemberton, Philip W. +13 more
core +1 more source
Objective To evaluate age-related variations in ovarian reserve among women in Kumasi, Ghana, and determine the preferred first-choice biomarker, either anti-Müllerian hormone or antral follicle count, in a low-resource setting. Methods A cross-sectional
Francis Jojo Moses Kwadzo Damalie +7 more
doaj +1 more source

